An experimental coronavirus vaccine made by Moderna provoked promising immune responses and appeared safe in the first 45 people who received it, researchers reported on Tuesday. Phase 3 tests involving 30,000 people are expected to begin on July 27.
nyti.ms/2ZrQwn1 pic.twitter.com/Clk9jJJFGo

7527 likes, 3932 retweets
mikenov on Twitter
Advertisements | Advertising at The News And Times - advertising-newsandtimes.com | WE CONNECT!